Advocat, Inc. (AVCA)

All Comments on AVCA

  • commenter
    Aug 07 12:20 PM
    Six Stocks with Possibilities [view article]
    ALL stocks have possibilities! Give me a break. "Haven't done the research," "may start a position,"... You don't have to tell us what you are doing each day. I am sorry, but this article is useless. Reply
  • commenter
    May 08 06:40 PM
    My Website
    Advocat: Compelling Opportunity in the Health Care Sector [view article]
    Another strong earnings report out of the company today although the stock seems to be stuck in neutral. Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:17 AM
    My Website
    General Discussion on AVCA
    Is this a buy or a sell? Reply
  • commenter
    Mar 12 06:43 AM
    My Website
    Advocat: An Undervalued Situation Requiring an Activist Touch [view article]
    FYI contact email should be amit.chokshi@kinnaras.... thanks. Reply
  • commenter
    Feb 02 02:25 PM
    Advocat Earnings: Not Good Enough [view article]
    I just took a quick peek at AVCA.
    The accounts receivables appears very
    high compared to the revenue growth.
    Are these bad debts, or are they fluffing
    up the revenue? I like cash flow (free) but
    there is not enough to catch my interest as
    yet.
    Good luch with the stock.
    Reply
  • commenter
    Nov 09 08:35 AM
    My Website
    Advocat Earnings: Not Good Enough [view article]
    I am a bit disappointed by the numbers and while the stock got hammered in AH trading, I still believe it's a good buy. AVCA's industry doesn't grow their top line on a "same-stores"... basis all that much, new centers need to be opened to really drive growth. Even in 2005 the Company had about 6.5% sales growth from 2004. The company is still making the right moves, you noted the restructuring of their convertible preferred which was an excellent move, and they also got a exchange listing.

    The tax benefit did mask what the real operating performance was but keep in mind the same thing happened in Q2 with a big reversal in professional liability costs. This stock's valuation relative to Kindred and other competitors is very attractive so while I'd prefer to see some better growth I'm content with solid cash flow and the changes management is making.
    Reply